"Contraceptives - Pipeline Review, H2 2012" now available at Fast Market Research

Sept. 19, 2012 - PRLog -- Global Markets Direct's, 'Contraceptives - Pipeline Review, H2 2012', provides an overview of the Contraceptives therapeutic pipeline. This report provides information on the therapeutic development for Contraceptives, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Contraceptives. 'Contraceptives - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Contraceptives.
* A review of the Contraceptives products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Contraceptives pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/463882_contraceptives_pipeline...
------------------------------------------------------------

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Contraceptives.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Contraceptives pipeline depth and focus of Contraceptives therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Contraceptives Therapeutic Products under Development, Key Players in Contraceptives Therapeutics, Contraceptives Pipeline Overview, Contraceptives Pipeline, Contraceptives Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Contraceptives Overview
Therapeutics Development
An Overview of Pipeline Products for Contraceptives
Contraceptives Therapeutics under Development by Companies
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Contraceptives Therapeutics - Products under Development by Companies
Companies Involved in Contraceptives Therapeutics Development
Antares Pharma, Inc.
Watson Pharmaceuticals, Inc.
Merck & Co., Inc.
BioSante Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited
Bayer AG
Ligand Pharmaceuticals Incorporated
HRA Pharma, SA
Pantarhei Bioscience BV
Hydra Biosciences, Inc.
Agile Therapeutics, Inc.
Adamis Pharmaceuticals Corporation
CONRAD
Contraceptives - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
MK-8175A - Drug Profile
Product Description
Mechanism of Action
R&D Progress
YAZ-Flex - Drug Profile
Product Description
Mechanism of Action
R&D Progress
FC Patch Low - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pill-Plus - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NestraGel - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HRA 081025 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Estetrol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ARC - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CatSper Program - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nestorone MDTS - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DR-104 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
UPA-CVR - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AG200-15 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AG-890 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DR-102 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Tanaproget - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Norethindrone Acetate Transdermal Delivery System - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LNG20 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Savvy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Meloxicam - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Contraceptive Patch Program - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Quartette - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MK-8342 - Drug Profile

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=4638...

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.